Sporadic parathyroid adenoma: an updated review of molecular genetics

Front Endocrinol (Lausanne). 2023 May 8:14:1180211. doi: 10.3389/fendo.2023.1180211. eCollection 2023.

Abstract

Introduction: Primary HPT (PHPT) is a common disorder, affecting approximately 1% of the general population. Parathyroid adenomas emerge as non-familial sporadic in 90% of cases. The aim of this review is to give a detailed update of molecular genetics of sporadic parathyroid adenoma reported in international literature.

Methods: A bibliographic research was conducted in PubMed, Google Scholar, and Scopus.

Results: Seventy-eight articles were included in our review. CaSR, MEN1, CCND1/PRAD, CDKI, angiogenic factors like VEGF, FGF, TGFβ, and IGF1, and apoptotic factors are important genes in parathyroid adenomas pathogenesis that have been established by several studies. A huge list of proteins is differently expressed in parathyroid adenomas measured by Western Blotting, MALDI/TOF, MS spectrometry, and immunohistochemistry. These proteins take part in several cell processes such as cell metabolism, cytoskeleton structural stability, cell oxidative stress regulation, cell death, transcription, translation, cell connection, and cell signaling transmission, while they can be found over- or underexpressed in abnormal tissues.

Conclusion: This review gives a detailed analysis of all reported data on genomics and proteomics of parathyroid adenoma. Further studies should be applied on understanding parathyroid adenoma pathogenesis and introducing new biomarkers for early detection of primary hyperparathyroidism.

Keywords: parathyroid adenoma; parathyroid adenoma tumorigenesis; parathyroid genomis; parathyroid pathogenesis; parathyroid proteomics.

Publication types

  • Review

MeSH terms

  • Blotting, Western
  • Cell Cycle
  • Cell Death
  • Humans
  • Molecular Biology
  • Parathyroid Neoplasms* / genetics